Delivery Order SPE2DP20D0004-SPE2DP20F5636
- Not listed
- This federal contract award, valued at $1,754,655.00, was issued by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and production. The contract is a Delivery Order under a broader Indefinite Delivery Indefinite Quantity (IDIQ) contract, with a firm fixed price pricing type and an ultimate completion date of September 27, 2024. Seqirus USA Inc. has been awarded numerous federal contracts to...
- The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
- This federal contract award, identified as SPE2DP16D0005|0001, is for the delivery of influenza virus vaccines. The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The contract is a firm-fixed-price delivery order with a ceiling value of $10,003,042.50 and a performance period ending on September 30, 2016. The contract was awarded by the...
- This federal contract award, with an ID of SPE2DP24D0004|SPE2DP24F7882, is for the delivery of influenza virus vaccines. The contract was awarded to the prime contractor, Seqirus USA Inc., through its Seqirus Usa, Inc. division. The contract has a ceiling value of $3,825.00 and is a firm-fixed-price delivery order. The contracting agency is the Medical Supply Chain, a component of the Defense Logistics Agency. The contract does not have a set-aside designation. Seqirus USA Inc. is a global...
- This is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccine development and delivery. The order, valued at $9,597,690.00, is for the supply of influenza virus vaccines. Seqirus USA Inc. has been awarded multiple federal contracts and task orders to provide influenza vaccines to various government healthcare programs and agencies, including the Department of Veterans Affairs,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $179,917.20 contract is for the delivery of influenza virus vaccines to support immunization programs for military personnel. Seqirus USA Inc., through its Seqirus USA, Inc. Division, has provided influenza vaccines to various federal government customers including the Department of Veterans...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the provision of influenza virus vaccines. The contract, valued at $12,072,680.00, has an ultimate completion date of October 13, 2023. Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The company holds several...
- This federal contract award is for the delivery of flu vaccines by Seqirus USA Inc., a global biotechnology company, to various U.S. government agencies including the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and Department of Justice. The contract, valued at $1,351,500.00, is a Firm Fixed Price Purchase Order with a completion date of July 7, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,102,020.00 firm fixed-price delivery order contract to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 13, 2023. This delivery order is part of Seqirus's existing Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency and Centers for Disease Control and Prevention, which allow federal agencies...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines. The contract has a ceiling value of $2,908,197.50 and an ultimate completion date of October 13, 2023. It is a firm fixed-price contract for the delivery of influenza virus vaccines. The contract is not set aside for any specific type of...
- SPE2DP20D0004Indefinite Delivery Contract
- SPE2DP20D0004-SPE2DP20F5636Delivery Order
This federal contract award is for the delivery of influenza virus vaccines to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DOD). The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development and delivery of influenza vaccines. The contract is a Firm Fixed Price Delivery Order with a potential value of $17,728,962.81 and a completion date of November 16, 2020. This contract was not set aside for any specific business types. Seqirus USA Inc. has been awarded numerous federal contracts and delivery orders to provide influenza vaccines to various government agencies and healthcare programs, including the Department of Veterans Affairs, the Department of Justice Bureau of Prisons, and the Department of Health and Human Services. Seqirus USA Inc. holds several high-value Indefinite Delivery Contracts (IDCs) and Indefinite Delivery Indefinite Quantity (IDIQ) contracts to supply influenza vaccines to federal agencies annually, including a $69 million IDIQ from the Department of Veterans Affairs National Acquisition Center and a $143 million IDC from the Centers for Disease Control and Prevention (CDC) for adult influenza vaccines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($11k) | 2/15/24 | |
| Not listed | Not listed | $17.7m | 6/19/20 |